INC Research - Contract Research Organisation (CRO) Contract Research Organisation (CRO) Resources Clinical Research Investigators Contract Research Organisation (CRO) Careers Contact INC Research Contract Research Organisation (CRO)
AVOS Consulting, A Division of INC Research

The healthcare industry currently faces an economic environment that differs greatly from recent history.

To address the challenges our customers face in the rapidly evolving global marketplace, INC Research integrated a world-class consulting team into our full service offering. AVOS Consulting, A Division of INC Research is now fully engaged on behalf of our customers worldwide.

Formerly an independent strategic consulting and research products firm focused on the evolving healthcare environment, the AVOS team places a sharp focus on key issues and pressure points faced by pharmaceutical, biotech, device, diagnostic and healthcare service clients. AVOS Consulting, as part of INC Research, is well positioned to help our customers address current and future economic concerns and to successfully compete in the increasingly challenging global environment.
 
AVOS Consulting capabilities and expertise are built upon its people who are widely recognized for their leading-edge insight and expertise. Collectively the AVOS principals bring 50+ years of executive healthcare experience working directly for life sciences companies or for entities providing services to the life sciences firms. The combination of this domain knowledge and understanding of the complex healthcare industry with the highly evolved therapeutic foresight represented within INC Research assists our customers with critical, real-time decision making in today’s dynamic business environment.
 
The AVOS team has made an effort to develop analytical tools and expertise around several areas of need within the evolving healthcare industry. Areas where AVOS Consulting has developed intellectual property and extensive expertise include:
  • Total Shareholder Return (TSR) – The TSR offering provides insight into which performance measures drive valuation, in terms of share price or other measures, across the healthcare industry as well as within subsegments and individual companies.
  • Capital Allocation – A component of numerous offerings our analytical toolkit, AVOS Consulting is able to assess capital allocation both quantitatively and qualitatively across an organization and within segments (e.g., across R&D within an organization).
  • Value Maximization – Value Maximization analyzes the entire process of value creation within an organization, from research and development through to commercialization, highlighting the most efficient resourcing and spending in order to derive maximum value from an organization’s assets.
  • Portfolio Optimization – The Portfolio Optimization tool is both a stand-alone offering and a component of the Value Maximization toolkit. The offering takes into account real-world uncertainty and a risk-return framework within its modeling in order to determine the optimal portfolio for development.
  • New Development Models – As the industry looks to develop products more quickly with fewer resources and spend, AVOS Consulting continues to evaluate and engineer new development models as part of both our analytical toolkit and consulting engagements.
  • Pricing and Market Access – In an increasingly difficult reimbursement environment, it becomes critical for companies to consider commercial aspects and payer relationships throughout the entire development cycle in advance of product launch.

The focus of AVOS Consulting is to provide solutions to address our customer’s unique requirements, whether they are one-time problems, ongoing issues, or preparation for issues likely to manifest in the future. We strive to assist our clients with their highest priority needs, which not surprisingly are often the complex or even thorny issues facing their business.

For more information on AVOS Consulting, click here.

Download our Foresight Newsletter:
Preparing for Key Development Challenges in 2011: Q&A with Neil MacAllister, Chief Business Officer, INC Research and President, AVOS Consulting

INC Research Adds AVOS Life Sciences to Strengthen Strategic and Regulatory Consulting Group